✦ LIBER ✦

A phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma

✍ Scribed by U. Sulkowski; M. Büchler; P. Pederzoli; R. Arnold; P. Dinse; A. Kay; U. Haus; H.G. Beger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

622Phase I dose-escalation study in pati

✍ A.G. Morganti; V. Valentini; D. Smaniotto; V. Clarniello; L. Trodella; G. Viola; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 123 KB

5-fluorouracil–based chemoradiation in u

✍ Alessio G Morganti; Vincenzo Valentini; Gabriella Macchia; Gian Carlo Mattiucci; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Phase II study of thalidomide in patient

✍ Albert Y. Lin; Nathalie Brophy; George A. Fisher; Sam So; Christopher Biggs; Tor 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

Phase II study of erlotinib plus gemcita

✍ Takuji Okusaka; Junji Furuse; Akihiro Funakoshi; Tatsuya Ioka; Kenji Yamao; Shin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Phase II study of high-dose megestrol ac

✍ Veenhof, C.H.N.; van der Burg, M.E.L.; Nooy, M.; Aalders, J.G.; Pecorelli, S.; O 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 274 KB

6590 A phase II study of erlotinib plus

✍ Nakachi, K.; Okusaka, T.O.; Funakoshi, A.F.; Ioka, T.I.; Yamao, K.Y.; Ohkawa, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB